Beech Hill Advisors »

Regeneron Pharmaceuticals shares owned by Beech Hill Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Beech Hill Advisors from 13F filings

Historical chart of Beech Hill Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Beech Hill Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Beech Hill Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 1.8k 623.54

More positions owned by Beech Hill Advisors

Applied Materials (AMAT)
Blackstone Group Inc Com Cl A (BX)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Amazon (AMZN)
Select Sector Spdr Tr St Str Techn Etf (XLK)
Advanced Micro Devices (AMD)
Abbvie (ABBV)
UnitedHealth (UNH)
Broadcom (AVGO)
Micron Technology (MU)
Meta Platforms Cl A (META)
Merck & Co (MRK)
Microsoft Corporation (MSFT)
Eaton Corp SHS (ETN)

View all positions for Beech Hill Advisors

Top funds holding Regeneron Pharmaceuticals

BlackRock
Vanguard Capital Management
State Street Corporation
Dodge & Cox
Franklin Resources
Geode Capital Management
Invesco
T. Rowe Price Associates
Nuveen
Loomis, Sayles and
Wellington Management Company
Vanguard Portfolio Management
FMR
Goldman Sachs Group
Capital World Investors

View all funds holding Regeneron Pharmaceuticals